Deal has $900,000 greenshoe; Aegis Capital is the sole bookrunner
By Devika Patel
Knoxville, Tenn., April 4 - Cancer Genetics, Inc. said it priced its $6 million initial public offering of stock with a $900,000 greenshoe. It expects the shares to trade on the OTCBB under the symbol "CGIX."
The company will sell 600,000 common shares at $10.00 apiece.
Aegis Capital Corp. is the sole bookrunning manager.
Settlement is expected April 10.
The Rutherford, N.J., diagnostics company is focused on developing genomic-based, oncology tests and services.
| Issuer: | Cancer Genetics, Inc.
|
| Issue: | Common stock
|
| Amount: | $6 million
|
| Greenshoe: | $900,000
|
| Shares: | 600,000
|
| Price: | $10.00
|
| Warrants: | No
|
| Bookrunner: | Aegis Capital Corp.
|
| Co-manager: | Feltl and Co., Inc.
|
| Pricing date: | April 4
|
| Settlement date: | April 10
|
| Stock exchange: | OTCBB: CGIX
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
